Berlin: In a remarkable achievement for Pakistan’s healthcare system, the Pakistan Kidney and Liver Institute and Research Center (PKLI) has reported 100 percent survival in children suffering from acute-on-chronic liver failure (ACLF) who underwent timely living donor liver transplantation (LDLT).
The breakthrough results were presented at the International Pediatric Transplant Association (IPTA) congress in Berlin by Prof. Saeed Akhtar, Chairman of PKLI’s Board, who described the data as stronger than many leading Western institutions.
Every year, hundreds of children in Pakistan develop end-stage liver disease and require transplantation to survive, yet the lack of awareness, late diagnosis, and absence of an organized cadaveric donation system limit access to life-saving treatment. Against this backdrop, the PKLI study offers new hope by demonstrating that with rapid recognition and timely intervention, survival outcomes for children can be drastically improved.
All the surgeries in this series were performed by transplant surgeons led by PKLI’s Dean, Prof. Dr. Faisal Saud Dar, the pioneer of liver transplantation in Pakistan. Dr. Dar has performed over 2,000 successful liver transplants to date, introducing unique surgical techniques and procedures that have placed Pakistan on the global liver transplant map. His leadership in pediatric and adult liver transplantation has been recognized internationally, making him one of the most accomplished surgeons in the region.
The PKLI team studied five pediatric ACLF cases between January 2024 and March 2025. The children, aged between one and 15 years, included four boys and one girl. Most were suffering from Wilson’s disease while others had cryptogenic liver disease. Their liver disease severity scores were critically high, but transplants performed within 48 to 72 hours in four cases — and after 23 days in one case — resulted in full recovery. None of the children died within 30 days of surgery, and no major complications were reported.
Prof. Akhtar said the results underline the critical importance of early diagnosis, rapid donor mobilization, and surgical precision in pediatric liver transplants. “Our data proves that timely transplant is the difference between life and death. Pakistan now has evidence that matches and, in some respects, surpasses many Western centers,” he said, adding that research and data presentation are vital for restoring the dignity of Pakistan’s healthcare system globally.
He told participants in Berlin that PKLI is emerging as a strong international player in the field of liver transplantation and called for more collaboration with Pakistani institutions. “Just performing high volumes of quality surgeries is not enough. Unless we capture our data and present it at international forums, our achievements remain invisible,” he said.
The study also highlighted a major gap: there is still no universally accepted definition of ACLF in children. This leads to delays in recognition and inconsistent management worldwide. Prof. Akhtar urged international bodies to work with centers like PKLI to harmonize definitions, establish diagnostic thresholds, and build pediatric transplant registries.
“This was one of the biggest purposes of creating PKLI — to show that Pakistan can lead with quality data, innovation, and world-class outcomes,” he said, stressing that liver transplantation is not only about clinical excellence but also about positioning Pakistan on the world medical map.
Ends